Knight Therapeutics | GUD - Market Capitalization


Knight Therapeutics reported CAD987.42M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 125.74M 431.39M Jul/2026
Cronos Group USD 958.02M 45.05M Mar/2026
Dianthus Therapeutics USD 2.71B 1.87B Jul/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 136.51M 115.96M Jul/2026
Organon & Co USD 3.47B 1.9B Jul/2026
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 510M 70M Jul/2026
Viatris USD 15.73B 1.39B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026